Trial intelligence / Profile preview

Intraoperative esketamine for postoperative pain after laparoscopic bariatric surgery

ChiCTR2100054038Phase 4Recruiting

Sponsor
Third People's Hospital of Chengdu
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine in postoperative pain (4 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoint: Resting NRS pain assessment score. Started Dec 2021; status: recruiting.

02

Drugs

esketamine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2100054038.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100054038.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call